New York City-based medical device and software company Optain has announced the successful closure of its seed funding round, raising $12,000,000 in total. The funding round was led by Northwell Holdings and Aegis Ventures, two leading venture capital firms in the healthcare industry.

Optain is a company founded by Jeff Dunkel, with roots in Australia, and is committed to setting new standards in accurate and efficient patient care. The company uses advanced AI and automation to detect and prevent diseases in their earliest stages, with the eye as the gateway for this detection. Optain's technology is designed to empower people with easy-to-use medical devices and software that can help identify health issues before they become more serious.

Optain's technology is focused on helping patients get the care they need, when they need it, and with the highest level of accuracy possible. With its innovative approach to medical technology, Optain has already gained significant traction in the healthcare industry. The funding raised will be used to further develop and expand the company's product offerings and market reach.

"We are thrilled to announce the successful closing of our seed funding round," said Jeff Dunkel, founder of Optain. "We are grateful for the support of our investors, who share our vision for improving patient care through the use of advanced technology. With this funding, we will continue to push the boundaries of what is possible in the healthcare industry, and we look forward to making a positive impact on the lives of patients and healthcare providers."